Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma.
Mancuso K, Tacchetti P, Pantani L, Rocchi S, Rizzello I, Caratozzolo I, De Cicco G, Fusco A, Testoni N, Terragna C, Marzocchi G, Martello M, Borsi E, Dozza L, Cavo M, Zamagni E. Mancuso K, et al. Among authors: fusco a. Bone Marrow Transplant. 2020 Sep;55(9):1865-1867. doi: 10.1038/s41409-020-0844-2. Epub 2020 Feb 26. Bone Marrow Transplant. 2020. PMID: 32103147 No abstract available.
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study.
Rizzello I, Cavo M, Dozza L, Rivolti E, Petrucci MT, De Stefano V, Antonioli E, Tosi P, D'Agostino M, Morè S, Gozzetti A, Cea M, Barbato S, Tacchetti P, Pantani L, Mancuso K, Rocchi S, De Cicco G, Fusco A, Zamagni E. Rizzello I, et al. Among authors: fusco a. Leuk Lymphoma. 2021 Aug;62(8):1897-1906. doi: 10.1080/10428194.2021.1897805. Epub 2021 Mar 18. Leuk Lymphoma. 2021. PMID: 33733993
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma.
Tacchetti P, Rocchi S, Zamagni E, Barbato S, Rizzello I, De Cicco G, Pantani L, Mancuso K, Fusco A, Dozza L, Ursi M, Favero E, Terragna C, Testoni N, Cavo M. Tacchetti P, et al. Among authors: fusco a. Am J Hematol. 2022 Dec;97(12):1607-1615. doi: 10.1002/ajh.26747. Epub 2022 Oct 18. Am J Hematol. 2022. PMID: 36198076 Free PMC article.
Obesity in Prediabetic Patients: Management of Metabolic Complications and Strategies for Prevention of Overt Diabetes.
Chianelli M, Armellini M, Carpentieri M, Coccaro C, Cuttica CM, Fusco A, Marucci S, Nelva A, Nizzoli M, Ponziani MC, Sciaraffia M, Tassone F, Busetto L. Chianelli M, et al. Among authors: fusco a. Endocr Metab Immune Disord Drug Targets. 2024 May 20. doi: 10.2174/0118715303282327240507184902. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38778593
Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy.
Monda E, Boccia A, Altobelli I, Mauriello A, De Michele G, Siniscalchi S, Fusco A, Cirillo A, Rubino M, Verrillo F, Diana G, Cirillo C, Caiazza M, Bossone E, Della Corte A, Russo MG, Limongelli G. Monda E, et al. Among authors: fusco a. Int J Cardiol. 2024 May 5;408:132067. doi: 10.1016/j.ijcard.2024.132067. Online ahead of print. Int J Cardiol. 2024. PMID: 38714235
PEA-OXA restores cognitive impairments associated with vitamin D deficiency-dependent alterations of the gut microbiota.
Guida F, Iannotta M, Perrone M, Infantino R, Giorgini G, Fusco A, Marabese I, Manzo I, Belardo C, Di Martino E, Pagano S, Boccella S, Silvestri C, Luongo L, Di Marzo V, Maione S. Guida F, et al. Among authors: fusco a. Biomed Pharmacother. 2024 Apr 25;175:116600. doi: 10.1016/j.biopha.2024.116600. Online ahead of print. Biomed Pharmacother. 2024. PMID: 38670046 Free article.
1,126 results